Swedbank
VERA icon

Swedbank’s Vera Therapeutics VERA Stock Holding History

Swedbank’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.15M Buy
+50,000
New +$1.86M ﹤0.01% 646
2026
Q1 		– Sell
-121,200
Closed -$6.14M – 704
2025
Q4 		$6.14M Buy
121,200
+71,200
+142% +$2.53M 0.01% 552
2025
Q3 		$1.45M Buy
+50,000
New +$1.16M ﹤0.01% 629

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Swedbank's VERA Position: Q2 2026 in Review

Swedbank opened a new position in Vera Therapeutics (VERA) in Q2 2026: 50,000 shares worth $2.15M. The stake represents ﹤0.01% of the portfolio and ranks #646 among its holdings. This is a return to the name: Swedbank previously reported a position in VERA as recently as Q4 2025.

Swedbank first reported a position in VERA in Q3 2025 and has held it in 3 quarters since. The position peaked at $6.14M in Q4 2025. 220 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Swedbank held 50,000 shares of Vera Therapeutics worth $2.15M as of Q2 2026.
  • Vera Therapeutics was a new Swedbank position in Q2 2026.
  • Vera Therapeutics made up ﹤0.01% of Swedbank's portfolio in Q2 2026, its #646 holding.
  • Swedbank first reported a position in Vera Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • Swedbank's Vera Therapeutics position peaked at $6.14M in Q4 2025.
  • 220 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Swedbank's 13F filing for Q2 2026, filed 15 Jul 2026.